Literature DB >> 7829710

Clofazimine: a review of its medical uses and mechanisms of action.

J L Arbiser1, S L Moschella.   

Abstract

Clofazimine has been in clinical use for almost 40 years, but little is known of its mechanism of action. The primary indication for clofazimine is multibacillary leprosy, but it is useful in several infectious and noninfectious diseases, such as typical myocobacterial infections, rhinoscleroma, pyoderma gangrenosum, necrobiosis lipoidica, severe acne, pustular psoriasis, and discoid lupus erythematosus. Postulated mechanisms of action include intercalation of clofazimine with bacterial DNA and increasing levels of cellular phospholipase A2. Clinical experience, possible mechanisms of action, and side effects of clofazimine are summarized.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7829710     DOI: 10.1016/0190-9622(95)90134-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  31 in total

1.  Phagocytosed Clofazimine Biocrystals Can Modulate Innate Immune Signaling by Inhibiting TNFα and Boosting IL-1RA Secretion.

Authors:  Gi S Yoon; Sudha Sud; Rahul K Keswani; Jason Baik; Theodore J Standiford; Kathleen A Stringer; Gus R Rosania
Journal:  Mol Pharm       Date:  2015-06-05       Impact factor: 4.939

2.  Targeting Kv1.3 channels to reduce white matter pathology after traumatic brain injury.

Authors:  Thomas M Reeves; Patricia A Trimmer; Beverly S Colley; Linda L Phillips
Journal:  Exp Neurol       Date:  2016-06-11       Impact factor: 5.330

Review 3.  Molecule Property Analyses of Active Compounds for Mycobacterium tuberculosis.

Authors:  Vadim Makarov; Elena Salina; Robert C Reynolds; Phyo Phyo Kyaw Zin; Sean Ekins
Journal:  J Med Chem       Date:  2020-04-20       Impact factor: 7.446

4.  Mucosal pigmentation caused by imatinib: report of three cases.

Authors:  Chia-Cheng Li; Salman M Malik; Bart F Blaeser; Walid J Dehni; Sadru P Kabani; Niamh Boyle; Mary Toner; Sook-Bin Woo
Journal:  Head Neck Pathol       Date:  2011-12-31

5.  An Expandable Mechanopharmaceutical Device (1): Measuring the Cargo Capacity of Macrophages in a Living Organism.

Authors:  Phillip Rzeczycki; Tehetina Woldemichael; Andrew Willmer; Mikhail D Murashov; Jason Baik; Rahul Keswani; Gi Sang Yoon; Kathleen A Stringer; Nair Rodriguez-Hornedo; Gus R Rosania
Journal:  Pharm Res       Date:  2018-11-12       Impact factor: 4.200

6.  Overcoming clofazimine intrinsic toxicity: statistical modelling and characterization of solid lipid nanoparticles.

Authors:  Luíse L Chaves; Sofia Lima; Alexandre C C Vieira; Domingos Ferreira; Bruno Sarmento; Salette Reis
Journal:  J R Soc Interface       Date:  2018-02       Impact factor: 4.118

Review 7.  Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.

Authors:  M Gopal; N Padayatchi; J Z Metcalfe; M R O'Donnell
Journal:  Int J Tuberc Lung Dis       Date:  2013-03-25       Impact factor: 2.373

8.  The Physicochemical Basis of Clofazimine-Induced Skin Pigmentation.

Authors:  Mikhail D Murashov; Vernon LaLone; Phillip M Rzeczycki; Rahul K Keswani; Gi S Yoon; Sudha Sud; Walajapet Rajeswaran; Scott Larsen; Kathleen A Stringer; Gus R Rosania
Journal:  J Invest Dermatol       Date:  2017-10-16       Impact factor: 8.551

Review 9.  Host-Directed Therapies for Tuberculosis.

Authors:  David M Tobin
Journal:  Cold Spring Harb Perspect Med       Date:  2015-05-18       Impact factor: 6.915

Review 10.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.